Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Bortezomib × Clear all

NCT00085410 2017-07-02

Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder

Phase 2 Terminated

20 enrolled 13 charts

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular

NCT00083226 2014-10-30

Doxorubicin and Bortezomib in Treating Patients With Liver Cancer

Phase 2 Completed

42 enrolled 8 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT00077441 2013-06-04

Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular